Raltegravir Treatment Intensification Does Not Alter Cerebrospinal Fluid HIV-1 Infection or Immunoactivation in Subjects on Suppressive Therapy
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Raltegravir Treatment Intensification Does Not Alter Cerebrospinal Fluid HIV-1 Infection or Immunoactivation in Subjects on Suppressive Therapy
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 204, Issue 12, Pages 1936-1945
Publisher
Oxford University Press (OUP)
Online
2011-10-22
DOI
10.1093/infdis/jir667
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4+ T Cell Response
- (2011) Hiroyu Hatano et al. JOURNAL OF INFECTIOUS DISEASES
- Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study
- (2011) Emily L Ho et al. AIDS Research and Therapy
- Raltegravir penetration in the cerebrospinal fluid of HIV-positive patients
- (2010) Andrea Calcagno et al. AIDS
- Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort
- (2010) Marlene Smurzynski et al. AIDS
- Total Raltegravir Concentrations in Cerebrospinal Fluid Exceed the 50-Percent Inhibitory Concentration for Wild-Type HIV-1
- (2010) D. Croteau et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Incidence and Impact on Mortality of Severe Neurocognitive Disorders in Persons With and Without HIV Infection: A Danish Nationwide Cohort Study
- (2010) F.-X. Lescure et al. CLINICAL INFECTIOUS DISEASES
- Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy
- (2010) Ana Canestri et al. CLINICAL INFECTIOUS DISEASES
- Short‐Course Raltegravir Intensification Does Not Reduce Persistent Low‐Level Viremia in Patients with HIV‐1 Suppression during Receipt of Combination Antiretroviral Therapy
- (2010) D. McMahon et al. CLINICAL INFECTIOUS DISEASES
- Can HIV infection be eradicated through use of potent antiviral agents?
- (2010) Lina Josefsson et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Treatment Intensification Has no Effect on the HIV-1 Central Nervous System Infection in Patients on Suppressive Antiretroviral Therapy
- (2010) Aylin Yilmaz et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- HIV‐1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment
- (2010) Arvid Edén et al. JOURNAL OF INFECTIOUS DISEASES
- Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy
- (2010) I Everall et al. JOURNAL OF NEUROVIROLOGY
- HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
- (2010) Maria J Buzón et al. NATURE MEDICINE
- Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons
- (2010) E. J. Wright et al. NEUROLOGY
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study
- (2010) R. K. Heaton et al. NEUROLOGY
- Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+ Cell Infection
- (2010) Nancie M. Archin et al. PLoS One
- The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
- (2010) Rajesh T. Gandhi et al. PLOS MEDICINE
- Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection
- (2010) Lars Hagberg et al. AIDS Research and Therapy
- Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course
- (2009) Patrick R Harrington et al. AIDS
- Persistent Intrathecal Immune Activation in HIV-1-Infected Individuals on Antiretroviral Therapy
- (2009) Aylin Yilmaz et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Compartmentalization and Clonal Amplification of HIV-1 Variants in the Cerebrospinal Fluid during Primary Infection
- (2009) G. Schnell et al. JOURNAL OF VIROLOGY
- Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection
- (2009) Aylin Yilmaz et al. PLoS One
- Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy
- (2009) J. B. Dinoso et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Compartmentalized Human Immunodeficiency Virus Type 1 Originates from Long-Lived Cells in Some Subjects with HIV-1–Associated Dementia
- (2009) Gretja Schnell et al. PLoS Pathogens
- Antiretroviral Treatment Effect on Immune Activation Reduces Cerebrospinal Fluid HIV-1 Infection
- (2008) Elizabeth Sinclair et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Antiretroviral Therapy and Central Nervous System HIV Type 1 Infection
- (2008) Richard W. Price et al. JOURNAL OF INFECTIOUS DISEASES
- Failure of atorvastatin to modulate CSF HIV-1 infection: Results of a pilot study
- (2008) J. C. Probasco et al. NEUROLOGY
- Microbial Translocation Is Associated with Increased Monocyte Activation and Dementia in AIDS Patients
- (2008) Petronela Ancuta et al. PLoS One
- Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy
- (2008) S. Palmer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now